The new definition of pulmonary hypertension

European Respiratory Journal

Volumn 34, Issue 4, 2009, Pages 790-791

  Hoeper, M M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONSENSUS; EDITORIAL; HEART LEFT VENTRICLE; HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; REST; RIGIDITY; WORLD HEALTH ORGANIZATION;

HUMANS; HYPERTENSION, PULMONARY; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 70349640924     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00056809     Document Type: Editorial

References (16)

1. Dupuis J, Hoeper MM. Endothelin receptor antagonists in pulmonary arterial hypertension. Eur Respir J 2008; 31: 407-414.
2. Wilkins MR, Wharton J, Grimminger F, et al. Phosphodiesterase inhibitors for the treatment of pulmonary hypertension. Eur Respir J 2008; 32: 198-209.
3. Olschewski H, Gomberg-Maitland M. Prostacyclin therapies for the treatment of pulmonary arterial hypertension. Eur Respir J 2008; 31: 801-901.
4. Hatano S, Strasser T. Primary Pulmonary Hypertension: Report on a WHO Meeting, Geneva 15-17 October 1973. Geneva, World Health Organization, 1975.
5. Bass O, Gurtner HP. [Evolution of primary vascular pulmonary hypertension following ingestion of aminorex fumarate (Menocil). Preliminary communication]. Schweiz Med Wochenschr 1973; 103: 1794.
6. Galie N, Torbicki A, Barst R, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004; 25: 2243-2278.
7. Kovacs G, Berghold A, Scheidl S, et al. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 2009; 34: 888-894.
8. Behr J, Ryu JH. Pulmonary hypertension in interstitial lung disease. Eur Respir J 2008; 31: 1357-1367.
9. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J 2008; 32: 1371-1385.
10. Oswald-Mammosser M, Weitzenblum E, Quoix E, et al. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest 1995; 107: 1193-1198.
11. Hamada K, Nagai S, Tanaka S, et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 2007; 131: 650-656. (Pubitemid 46446853)
12. Oudiz RJ, Rubin LJ. Exercise-induced pulmonary arterial hypertension: a new addition to the spectrum of pulmonary vascular diseases. Circulation 2008; 118: 2120-2121.
13. Tolle JJ, Waxman AB, Van Horn TL, et al. Exercise-induced pulmonary arterial hypertension. Circulation 2008; 118: 2183-2189.
14. Badesch DB, Champion HC, Gomez-Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54: Suppl., S55-S66.
15. Galie N, Hoeper MM, Humbert M, et al. Guidelines on the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; In press.
16. Galie N, Hoeper MM, Humbert M, et al. Guidelines on the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2009; In press.